Founded in 2007, the cluster was funded for 5 years, with a total budget of €7M from SFI. SSPC grew and established itself as an international brand oﬀering expertise in additional areas.
Following extensive consultations, an application was made to become a Centre that focused on the entire pharmaceutical production chain from the synthesis of the molecule to the isolation of the material and the formulation of the medicine, delivered over three strands including spokes project awards. The full Centre proposal was submitted on September, 9, 2012 and the Centre was up and running by June 2013, for 6 years and a total budget of €40M from SFI.
Now in it’s second iteration, SSPC was funded in 2019, with a total budget of €61M. Having expanded into manufacturing and modelling.
Our successful inter-industry collaborations have worked because of the input from the expertise within our academic and industry partners
The research carried out by SSPC crosses the pharmaceutical production chain from molecule to medicine, with the objective of gaining a better understanding of mechanisms, controlling processes, and predicting outcomes for the efficient and environmentally sustainable production of safe medicines.
Specific areas of expertise include catalysis for organic synthesis, flow chemistry, theranostics, informed formulation for poorly soluble drugs, crystallization, solid form selection, continuous manufacturing, peptide/protein production routes and characterisation, novel reactor technology, process, molecular and mathematical modelling.